MetaCap

Translational Development Acquisition Corp. - Units (TDACU)

NASDAQ: TDACUFinancial ServicesShell CompaniesUSD

12.27+0.16 (+1.32%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

TDACU stock chart

Technical analysis

Key statistics

All statistics

TDACU stock today

Shares of Translational Development Acquisition - Units (TDACU) finished higher on Oct 8 at $12.27, a gain of 1.32% or $0.16 per share, versus the S&P 500's 0.47% decline. Volume was 11.0x the average at 320 shares, a sign of unusually heavy trading. Shares are 29.0% below their 52-week high of $17.29, set on May 26, 2026 and 17.5% above the 52-week low of $10.44, in the middle of the past year's range.

TDACU is up 17.5% year to date, outperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has gained 17.5%.

Summary generated from market data by MetaCap's automated system. Methodology

About Translational Development Acquisition - Units

Company profile

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Industry
Shell Companies
CEO
Mr. Michael M. B. Hoffman J.D.
Headquarters
New York, NY
IPO year
2024

Translational Development Acquisition - Units peers

Financial Services sector

Indexes, lists and sector

Translational Development Acquisition - Units stock FAQ

What is Translational Development Acquisition - Units's stock price today?

TDACU last traded at $12.27 as of Oct 8, 4:00 PM EDT, up 1.32% on the day. Prices are delayed at least 15 minutes.

Who is Translational Development Acquisition - Units's CEO?

Mr. Michael M. B. Hoffman J.D. is the chief executive officer of Translational Development Acquisition Corp. - Units.

What is the TDACU 52-week high?

The 52-week high for TDACU is $17.29 and the 52-week low is $10.44. The stock is currently 29.0% below its high.

Compare TDACU